Catherine Bourassa
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- HIV/AIDS drug development and treatment
- SARS-CoV-2 detection and testing
- Virology top 5%
- HIV Research and Treatment
Papers in
- Virology 18
- HIV Research and Treatment 18
-
- SARS-CoV-2 and COVID-19 Research 19
- COVID-19 Clinical Research Studies 4
- HIV/AIDS drug development and treatment 3
- Co-authors
- Andrés Finzi (23 shared papers)Jonathan Richard (17 shared papers)Halima Medjahed (17 shared papers)Guillaume Goyette (7 shared papers)Gabrielle Gendron‐Lepage (9 shared papers)Alexandra Tauzin (11 shared papers)Jérémie Prévost (8 shared papers)Guillaume Beaudoin-Bussières (10 shared papers)
- Journals
- Viruses (9 papers)mBio (5 papers)Journal of Virology (4 papers)Cell Reports (3 papers)Cell Host & Microbe (3 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Catherine Bourassa
39 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 63
- Infectious Diseases 987
- Virology 142
- Immunology 52
- General Dentistry 1
- Modeling and Simulation 8
Countries citing papers authored by Catherine Bourassa
This map shows the geographic impact of Catherine Bourassa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Bourassa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Bourassa more than expected).
Fields of papers citing papers by Catherine Bourassa
This network shows the impact of papers produced by Catherine Bourassa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Bourassa. The network helps show where Catherine Bourassa may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine Bourassa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 203 | |
| 2 | 2021 | 166 | |
| 3 | 2021 | 159 | |
| 4 | 2021 | 143 | |
| 5 | 2021 | 141 | |
| 6 | 2021 | 74 | |
| 7 | 2022 | 43 | |
| 8 | 2021 | 42 | |
| 9 | 2021 | 38 | |
| 10 | 2022 | 18 | |
| 11 | 2024 | 18 | |
| 12 | 2022 | 17 | |
| 13 | 2023 | 17 | |
| 14 | 2021 | 16 | |
| 15 | 2023 | 16 | |
| 16 | 2022 | 15 | |
| 17 | 2023 | 15 | |
| 18 | 2022 | 12 | |
| 19 | 2022 | 11 | |
| 20 | 2022 | 11 |
About Catherine Bourassa
Catherine Bourassa is a scholar working on Virology, Infectious Diseases, Immunology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 40 papers that have together received 1.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (19 papers), HIV Research and Treatment (18 papers), COVID-19 Clinical Research Studies (4 papers), HIV/AIDS drug development and treatment (3 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Infectious Diseases (987 citations), Virology (142 citations), Immunology (52 citations), General Dentistry (1 citation) and Modeling and Simulation (8 citations). Catherine Bourassa has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Andrés Finzi, Jonathan Richard, Halima Medjahed, Guillaume Goyette, Gabrielle Gendron‐Lepage, Alexandra Tauzin, Jérémie Prévost, Guillaume Beaudoin-Bussières, Amos B. Smith and Mehdi Benlarbi. Their work appears in journals such as Viruses, mBio, Journal of Virology, Cell Reports and Cell Host & Microbe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.